指南解读(Interpretation of Guidelines)

《肝细胞癌合并门静脉癌栓多学科诊治中国专家共识(2016年版)》解读

Published at: 2017年第26卷第7期

荚卫东 1 , 刘文斌 1
1 安徽省立医院 肝脏外科/肝胆胰外科安徽省重点实验室,安徽 合肥 230001
通讯作者 卫东 荚 Email: jwd1968@sina.com
DOI: 10.3978/j.issn.1005-6947.10.3978/j.issn.1005-6947.2017.07.001
基金:
安徽省重点研究与开发计划项目 1704a0802150

摘要

肝癌细胞容易侵犯肝内的脉管系统尤其是门静脉系统,形成门静脉癌栓(PVTT),一旦出现PVTT,病情发展迅速,提示预后不良。基于现有的循证医学证据,尤其是国内学者对肝细胞癌合并PVTT的研究结果,全国肝癌合并癌栓诊治研究协作组制定了《肝细胞癌合并门静脉癌栓多学科诊治中国专家共识(2016年版)》。笔者从PVTT分型及不同类型癌栓治疗方式选择等角度对共识进行了解读。


Interpretation of Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2016 edition)

Abstract

Hepatocellular carcinoma has a propensity to invade the intra-hepatic vascular system, especially the portal vein system and, therefore, leads to the formation of the portal vein tumor thrombus (PVTT). Once PVTT occurs, the disease will progress rapidly with a dismal prognosis. Based on the existing data of evidence-based medicine, particularly the results from research on hepatocellular carcinoma complicated with PVTT achieved by Chinese scholars, the Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2016 edition) has been developed by the National Research Cooperative Group for Diagnosis and Treatment of Hepatocellular Carcinoma with Tumor Thrombus. Here, the authors interpret the consensus from the aspects of the PVTT classification and treatment selection for different types of tumor thrombus, etc.


comments powered by Disqus

全文

引用

引用本文: 卫东 荚, 文斌 刘. 《肝细胞癌合并门静脉癌栓多学科诊治中国专家共识(2016年版)》解读[J]. 中国普通外科杂志, 2017, 26(7): 815-820.
Cite this article as: JIA Weidong, LIU Wenbin . Interpretation of Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2016 edition) [J]. Chin J Gen Surg, 2017, 26(7): 815-820.